Abstract
Background and objectives
Epidemics of CKD of uncertain etiology (CKDu) are emerging around the world. Highlighting common risk factors for CKD of uncertain etiology across various regions and populations may be important for health policy and public health responses.
Design, setting, participants, & measurements
We searched PubMed, Embase, Scopus and Web of Science databases to identify published studies on CKDu. The search was generated in January of 2015; no language or date limits were used. We used a vote-counting method to evaluate exposures across all studies.
Results
We identified 1607 articles, of which 26 met inclusion criteria. Eighteen (69%) were conducted in known CKDu–endemic countries: Sri Lanka (38%), Nicaragua (19%), and El Salvador (12%). The other studies were from India, Japan, Australia, Mexico, Sweden, Tunisia, Tanzania, and the United States. Heavy metals, heat stress, and dietary exposures were reported across all geographic regions. In south Asia, family history, agrochemical use, and heavy metal exposures were reported most frequently, whereas altitude and temperature were reported only in studies from Central America. Across all regions, CKDu was most frequently associated with a family history of CKDu, agricultural occupation, men, middle age, snake bite, and heavy metal exposure.
Conclusions
Studies examining etiologies of CKDu have reported many exposures that are heterogeneous and vary by region. To identify etiologies of CKDu, designing consistent and comparative multisite studies across high-risk populations may help elucidate the importance of region–specific versus global risk factors.
Keywords: chronic kidney disease; nephrotoxicity; risk factors; global health; low- and middle-income countries; humans; occupations; public health; renal insufficiency, chronic; temperature
Introduction
CKD is a growing health burden globally with many known and unknown etiologies (1). In high-income countries, it is most commonly associated with noncommunicable diseases, such as diabetes and hypertension. However, in low- and middle-income countries, it has several additional potential etiologies, such as infectious diseases and environmental toxins, but many remain unknown (1–3). CKD of uncertain etiology (CKDu) is a term that has been used to describe CKD that is not attributable to any traditional risk factor, such as diabetes, hypertension, or HIV. CKDu is being reported with increasing frequency across the globe, and in many parts of Central America, eastern Europe, and south Asia, it is being reported in epidemic proportions (4–6).
The term CKDu was first used in El Salvador in the early 2000s to describe a disease predominantly affecting agricultural communities from large-scale plantations (7,8). Subsequently, this disease pattern, which was similar to that of Balkan Endemic Nephropathy (9), was reported in other countries, including Nicaragua, Costa Rica, and Sri Lanka (6,10–12), and its prevalence is now as high as 16% in some of these areas (13). In El Salvador, ESRD that is largely attributable to CKDu has become the leading cause of hospital deaths (8), and in Sri Lanka, nearly 4% of the national health care budget is now spent on treating CKDu (14,15). As such, it has become a public health priority and the focus of many World Health Organization–sponsored epidemiologic studies (16–18).
One proposed common feature of CKDu in these regions is its occurrence mainly in agricultural communities and most conspicuously, among young male farmers (19,20). Environmental factors, such as heavy metal exposures (21), high seasonal temperatures (22), agrochemical use, mycotoxins (23), contaminated water supplies, and snake bite (24), have all been studied as potential causes of CKDu. However, the underlying etiologies have not been clearly identified in most regions (18), and highlighting common risk factors across these global settings and populations could be important for understanding and preventing CKDu. Therefore, we performed a systematic review of the existing literature to identify common exposures and potential risk factors for CKDu across different global populations.
Materials and Methods
Search Strategy
We searched the PubMed, Embase, Scopus, and Web of Science databases to identify published studies. Search terms included a combination of relevant subject headings and text words for kidney disease (e.g., CKD and CKDu) and the potential exposures (e.g., agriculture, heavy metals, and ground water) (Supplemental Appendix 1). We narrowed our search to randomized trials and observational studies using the Cochrane Highly Sensitive Search Strategy filter for identifying randomized, controlled trials (25), which we expanded to include observational trials. Without limits on language or publication dates, the search was generated in January of 2015. We supplemented the search by screening both the cited and citing references of all included studies.
Selection Criteria
All abstracts were retrieved by two authors (J.L. and M.V.I.). Two authors (J.L. and D.M.) then independently reviewed each title and abstract for inclusion. Any disagreement resulted in a joint review of the full article with reconciliation that led to inclusion or exclusion.
After review of the abstracts, each article was independently reviewed in full by two authors (J.L. and D.M.). Studies were included if they assessed the association between CKDu and potential exposures and reported a statistical association between CKDu and exposures. Randomized, controlled trials and nonrandomized studies, including cross-sectional studies, cohort studies (retrospective or prospective), and case-control studies, were eligible for inclusion. Editorials, reviews, and case reports without the required data were excluded. We excluded studies if CKDu was not differentiated from CKD by failing to make the distinction in the case definition and/or failing to account for traditional risk factors for CKD, such as diabetes and hypertension.
Quality Assessment and Data Extraction
Each selected study was independently assessed by two authors (J.L. and D.M.) using standard quality assessment scales for observational studies (26,27). Cross-sectional, case-control, and cohort studies were assessed for quality on the basis of selection, comparability, and outcome measures (Supplemental Appendix 2). On the basis of these criteria, each article received a numeric quality score on a scale ranging from zero (lowest) to nine (highest) for cohort studies and from zero to 10 for case-control and cross-sectional studies. Studies with quality scores eight or higher were considered high quality. Studies with scores six or seven were considered medium quality, and studies with scores five or lower were considered to be low quality. Any disagreement resulted in joint review of the article with reconciliation. In cases where reconciliation was not achieved, a third author (J.W.S.) independently reviewed the articles to provide majority consensus.
Two authors (J.L. and D.M.) independently extracted the data from all included studies, and they entered the data independently and in duplicate into a preformulated table. Errors in data extraction were resolved by joint review of the original articles. We extracted the study characteristics, including authors, study dates, study location, sample size, and study design, and we extracted the measured exposures for CKDu, including heavy metals, water hardness, ambient temperature, agrochemical use, heat stress, demographics (age, sex, and occupation), family history of CKDu, smoking, herbal use, snake bites, and diet. In cases of uncertainty or missing data, we attempted to contact the corresponding authors for additional information.
Statistical Analyses
We assessed inter-rater agreement for inclusion and quality assessment using Cohen κ-coefficient, and using an I2 statistic, we investigated heterogeneity across the medium– and high–quality case-control studies for the most commonly reported risk factors from these studies. Because we wanted to describe the range of potential exposures that may contribute to CKDu, we used a vote-counting method to evaluate the exposures across the different studies. For application to studies on CKDu, this method had the advantage of providing a descriptive summary of a range of variables across heterogeneous studies. It did not provide estimates pertaining to the magnitude or influence of a particular variable, which would be expected in a meta-analysis (28).
We assigned a positive (+), negative (−), or null (0) value for each association between exposure and outcome (CKDu) that was measured in the individual studies. To receive a positive or negative value, the association had to be reported as significant in the positive or negative direction, respectively, at a P value <0.05. In cases where the association was reported as not statistically significant (P>0.05), a null value was assigned. For associations in which P values were not reported, no entry was assigned (Supplemental Appendix 3).
Results
We identified 1607 articles for review. Review of the title and abstracts yielded 89 articles for full-text review, and one additional article, which was in press at the time of the search but known to the authors, was included. The full-text review yielded 26 articles for final inclusion (Figure 1). Inter-rater agreement for the included articles was excellent (κ=0.90). Of 26 included studies, 18 (69%) were conducted in known CKDu-endemic countries, including Sri Lanka (10; 38%), Nicaragua (five; 19%), and El Salvador (three; 12%) (Tables 1 and 2). The other studies were from India, Japan, Australia, Mexico, Sweden, Tunisia, Tanzania, and the United States. All included studies were conducted between 2003 and 2015. Most were cross-sectional (12; 46%) or case-control (12; 46%), and only two were cohort designs (Table 1).
Figure 1.
Flow diagram illustrating included and excluded studies in the systematic review.
Table 1.
Characteristics of studies included in the systematic review
Authors | Country | Year | Sample Size, n | Design | Quality |
---|---|---|---|---|---|
South Asia | |||||
Siriwardhana et al. (47) | Sri Lanka | 2014 | 200 | Case-control | Medium |
Nanayakkara et al. (39) | Sri Lanka | 2014 | 815 | Case-control | High |
Bandara et al. (48) | Sri Lanka | 2008 | 64 | Case-control | Low |
Chandrajith et al. (12) | Sri Lanka | 2011 | 44 | Case-control | Low |
Athuraliya et al. (29) | Sri Lanka | 2011 | 6153 | Cross-sectional | High |
Jayatilake et al. (17) | Sri Lanka | 2013 | 627 | Cross-sectional | High |
Wanigasuriya et al. (21) | Sri Lanka | 2011 | 886 | Cross-sectional | High |
Nanayakkara et al. (49) | Sri Lanka | 2012 | 237 | Case-control | Medium |
Wanigasuriya et al. (24) | Sri Lanka | 2007 | 383 | Case-control | Medium |
Rango et al. (45) | Sri Lanka | 2015 | 134 | Case-control | Medium |
Siddarth et al. (38) | India | 2013 | 668 | Case-control | Medium |
Central America | |||||
VanDervort et al. (50) | El Salvador | 2014 | 16,384 | Cross-sectional | High |
Orantes et al. (4) | El Salvador | 2011 | 775 | Cross-sectional | Medium |
Peraza et al. (32) | El Salvador | 2012 | 664 | Cross-sectional | High |
Torres et al. (20) | Nicaragua | 2010 | 1096 | Cross-sectional | Medium |
Laux et al. (22) | Nicaragua | 2012 | 267 | Cross-sectional | Medium |
O'Donnell et al. (31) | Nicaragua | 2011 | 771 | Case-control | High |
Sanoff et al. (51) | Nicaragua | 2010 | 997 | Case-control | Medium |
Raines et al. (30) | Nicaragua | 2014 | 424 | Cross-sectional | High |
Nonendemic | |||||
Maruzeni et al. (52) | Japan | 2014 | 9446 | Cohort | Medium |
Ivey et al. (33) | Australia | 2013 | 948 | Cohort | Medium |
Robles-Osorio et al. (53) | Mexico | 2012 | 90 | Cross-sectional | Medium |
Sommar et al. (54) | Sweden | 2013 | 496 | Case-control | High |
Abid et al. (55) | Tunisia | 2003 | 1159 | Case-control | Low |
Stanifer et al. (37) | Tanzania | 2015 | 481 | Cross-sectional | High |
Sontrop et al. (56) | United States | 2013 | 3427 | Cross-sectional | Medium |
Table 2.
Study sites by region
Countries | Studies, n (%) |
---|---|
South Asia | 11 (42) |
Sri Lanka | 10 (38) |
India | 1 (4) |
Central America | 8 (31) |
Nicaragua | 5 (19) |
El Salvador | 3 (12) |
Other regions | 7 (27) |
Japan | 1 (4) |
Australia | 1 (4) |
United States | 1 (4) |
Tunisia | 1 (4) |
Tanzania | 1 (4) |
Sweden | 1 (4) |
Mexico | 1 (4) |
Ten (38%) studies met the criteria for high quality, 13 (50%) studies met the criteria for medium quality, and three (12%) were considered low quality (Table 1). The inter-rater agreement for study quality was excellent (κ=0.90). The common reasons for studies not meeting high-quality criteria were failure to report the nonresponse rate (24 [92%] case-control and cross-sectional studies), failure to justify sample size (21 [81%] studies), and inadequacy of follow-up (one [4%] cohort study). Several studies were also limited by their lack of validated measurements or clear descriptions of the methods used to measure risk factors (Supplemental Appendix 2). For medium– and high–quality case-control studies conducted in endemic regions, we noted significant heterogeneity across studies in the reported estimates for the two most commonly reported risk factors for CKDu (farming occupation: n=5; I2=84.3%; P<0.01 and men: n=5; I2=73%; P<0.01) (Supplemental Appendix 4).
Risk factors most frequently measured were age (n=13; 50%), occupation (n=12; 46%), sex (n=12; 46%), agrochemical use (n=10; 38%), heavy metals (cadmium, arsenic, lead, and aluminum; n=9; 35%), smoking (n=8; 31%), family history of CKDu (n=7; 27%), body mass index (BMI; n=7; 27%), alcohol intake (n=6; 23%), and heat stress (n=5; 19%). Other less frequently measured risk factors included water hardness (n=3; 12%), altitude (n=3; 12%), dietary exposure (e.g., rice and rice products, fish and seafood, legumes, and meats; n=3; 12%), tobacco chewing (n=2; 8%), snake bite (n=2; 8%), ochratoxin A (a mycotoxin; n=1; 4%), ambient temperature (n=1; 4%), and herbal medicines (n=1; 4%).
All studies (n=11) that reported temperature, altitude, dietary exposure, ochratoxin A, herbal use, and snake bite found a significant association between CKDu and these exposures (Figure 2A). These studies were all conducted in Central America and South Asia. Significant associations were also reported for family history of CKDu (n=6), age (n=10), men (n=9), and heat stress (n=4). Water hardness was not reported in any study as significantly associated with CKDu, and smoking was only reported as significant in one study (21).
Figure 2.
Frequency of measured exposures from studies across different regions. (A) Exposures measured in studies from all regions; (B) exposures measured in studies from South Asia; (C) exposures measured in studies from Central America. BMI, body mass index.
Heavy metals, heat stress, and dietary exposures were reported in studies across all geographic regions (Figure 2A); however, we did observe regional heterogeneity in the other exposures reported (Table 3). Family history (n=5), agrochemical use (n=4), and heavy metal exposures (n=6) were reported most frequently in studies from South Asia, whereas altitude (n=3) and temperature (n=1) were reported only in studies from Central America.
Table 3.
Five most frequently studied CKD of uncertain etiology risk factors by region
CKDu Risk Factors by Region | Frequency |
---|---|
South Asia (n=11; 42%) | |
Heavy metals | 6 |
Occupation (farmer) | 6 |
Family history | 5 |
Agrochemical use | 4 |
Smoking | 4 |
Central America (n=8; 31%) | |
Age | 7 |
Men | 7 |
Agrochemical use | 6 |
Occupation (farmer) | 5 |
Heat stress | 3 |
Other regions (n=7; 27%) | |
Body mass index | 3 |
Heavy metals | 2 |
Age | 2 |
Dietary exposure | 1 |
Heat stress | 1 |
CKDu, CKD of uncertain etiology.
In South Asia, heavy metals (n=6), occupation (n=6), and family history (n=5) were studied most frequently. Family history (n=5), snake bites (n=2), dietary history (n=1), tobacco chewing (n=1), herbal use (n=1), and heat stress (n=1) were found to be positively associated with CKDu in all studies that reported these exposures. Exposures associated with a lower risk of CKDu were higher BMI (n=1), men (n=1), agrochemical use (n=1), and heavy metals (n=1) (Figure 2B). In the high-quality studies from this region, which were all conducted in Sri Lanka, the prevalence of CKDu among high-risk populations was reported to be 14.9% (17), 9.5% (29), and 7.3% (21).
In Central America, age (n=6), sex (n=6), and occupation (n=6) were studied most frequently. Age (n=6), men (n=6), low altitude (n=3), high ambient temperatures (n=1), and dietary history (n=1) were found to be positively associated with CKDu in all of the studies that reported them. Higher BMI and heat stress were negatively associated with CKDu in one third of the studies that reported them (Figure 2C). Among high-risk populations from this region, the prevalence of CKDu in high-quality studies was reported to be 25.9% and 13.0% in Nicaragua (30,31) and 18.0% in El Salvador (32).
In nonendemic countries (four of which were the high-income countries of the United States, Sweden, Japan, and Australia), BMI (n=2) and heavy metals (n=2) were studied most frequently as potential exposures related to CKDu. Heavy metals (n=2), heat stress (n=1), and ochratoxin A (n=1) were found to be positively associated with CKDu in all of the studies that reported these exposures. The single study that suggested that dietary intake was associated with a lower risk of CKDu examined the protective role of proanthocyanidins on kidney function among elderly Australian women (33).
Discussion
Despite an increasing global awareness of CKD and CKDu, many of the risk factors remain unknown (1). We identified many potential risk factors for CKD that may vary by region, but the heterogeneity in their reported associations with CKD limits conclusions about the etiologies of CKDu. In South Asia, family history, agrochemical use, and heavy metal exposures were studied most frequently, whereas altitude and temperature were studied only in Central America. However, many similarities also exist. Heavy metals, heat stress, and dietary exposures were reported in studies across all geographic regions, and family history, temperature, altitude, dietary exposure, ochratoxin A, herbal use, and snake bite were frequently reported in both South Asia and Central America.
Given the similarities and the differences observed in studies across the regions, the growing CKD burden may, in part, be driven by factors that are common across regions as well as unique within regions. Pathologic exposures can affect disease outcomes by interacting with a wide range of factors, including source emissions, transport and transformation, human contact, bioavailability, early expression of disease, and/or health effects (34). In low-income countries, for example, rapid urbanization has led to poor sanitation, unplanned infrastructure, overcrowding, and environmental pollution (35,36). For CKD, these exposures may interact with other urban risk factors, such as high rates of noncommunicable and communicable diseases, to increase CKD prevalence (37).
Likewise, in rural, low–income areas, extreme poverty and agricultural-based economies expose people to other CKD risk factors, such as dehydration, snake bite, water contamination, heavy metals, and agrochemicals, which can also interact with noncommunicable and communicable diseases as well as genetic factors to increase CKD risk (1,3). As such, the regional variation in reporting of risk factors for CKDu may reflect a complex interplay between different global and regional exposures and local factors, such as environment and lifestyle.
One example of regional variation in the reporting of risk factors for CKDu was observed with dehydration. Although dehydration is increasingly being posited as a potential etiologic factor for CKDu in endemic communities (22), assessment of the associations between dehydration and CKDu across studies was limited by inconsistent reporting of the measurements for assessing dehydration. For example, whereas all studies that measured variation in altitude and seasonal temperature reported a significant association between dehydration and CKDu, studies reporting heat stress infrequently reported an association between dehydration and CKDu. This highlights the importance of designing standardized measurements to consistently and comparatively assess the role of dehydration in the etiology of CKDu across the world.
Additionally, genetics may also play a role in the observed regional heterogeneity in the reported epidemiology of CKDu. Genetic differences in ethnicities are known to have a strong effect on the prevalence and risk of progression of CKD. In the United States, for example, Americans of African descent who carry the APOL1 genotype have higher rates and faster progression of CKD, especially when exposed to other augmenting factors, such as diabetes and hypertension. In India and Sri Lanka, there are specific polymorphisms (38) and single-nucleotide mutations (39) that have been associated with CKDu in some endemic communities, and in the Balkan states, particular chromosomal aberrations have been associated with Balkan Endemic Nephropathy (40,41). Therefore, more studies should be conducted to explore the role of genetic predisposition in the CKDu disease mechanism.
Agrochemical use has been widely considered to be a risk factor for CKDu, and it may be important to distinguish CKDu in agricultural communities from CKDu in other regions across the world (11–13). Agrochemicals, such as glyphosate, organochlorine compounds, and paraquat, are used across the globe in farming communities as pesticides and herbicides. However, despite their use, there are safety concerns about their health effects, including oxidative damage to the kidneys (42). In our review, only two studies from Sri Lanka and two studies from Central America reported a significant association between agrochemical use and CKDu. Agrochemical use was not reported in studies from other regions, suggesting the possibility of a distinct etiology for CKD in agricultural communities in CKDu-endemic regions (6,11–14). These findings may reflect variation in the regional exposures being studied as well as difficulties in defining and quantifying agrochemical exposure, but they also highlight the need for more conclusive epidemiologic studies examining causation, particularly in agricultural communities in CKDu-endemic regions.
Additionally, the causal association between heavy metals and CKDu is not well established, and we observed significant variability in the reported associations. For example, cadmium was inconsistently reported to be associated with CKDu, whereas arsenic was consistently associated with CKDu. We also observed regional heterogeneity in the reporting of heavy metals as a risk factor for CKDu. Only one study from Central America reported heavy metals, whereas six studies from South Asia reported it. It is likely that heavy metals do play a role in the development of CKDu in endemic areas, where levels are often present in the microenvironment and multiple other risk factors coexist (43–45). However, because the microenvironment and human levels of heavy metals from CKDu-endemic regions have been reported to be below the upper limits of detection, exploring mechanisms of interaction between heavy metals and other risk factors may be important in advancing CKDu research (12,39,44–46).
Our study has many strengths. Because of the limited epidemiologic data regarding CKDu, we chose not to limit our systematic review to any particular population, region, or time period, and our comprehensive search is one of the broadest assessments of CKDu globally to date. Also, our systematic approach provides a reproducible method and descriptive summary for other investigators examining CKDu.
We noted limitations as well. Because we observed significant heterogeneity among the studies, even within regions, we were not able to synthesize the data using meta-analytic techniques. Instead, we used a vote-counting method, which itself has several limitations. Typically, it assigns equal weights to the findings of different included studies. This can be problematic when quality is variable and effect sizes are not incorporated in any way. In the studies that we reviewed, sample sizes varied, and some may have been underpowered or limited in precision in their reporting of CKDu risk factors, which may have introduced a reporting bias. Finally, our findings are descriptive in nature. Studies were not weighted by quality or sample size, and the magnitudes of association were often not reported; therefore, conclusions about the relative importance of potential risk factors are limited. However, vote counting can provide a useful starting point for a systematic assessment of studies within a given research area, especially when there is a lack of agreement or consensus in the literature and when the nature of relationships across disparate sites and methodologies is not well described. Given that little is known about the causes of CKDu, this approach may be useful for generating hypotheses that can inform future epidemiologic studies as well as determine uniform causes to evaluate in future studies.
In conclusion, we describe potential risk factors for CKD that have been studied globally, many of which vary by region and are heterogeneous in their reported associations with CKDu. It remains unknown whether the regional variation in CKDu risk factors reflects inconsistencies in measurement across studies, poor quality of studies, including sample size limitations, or complexity in the interactions between global exposures and local factors, such as environment, genetics, and lifestyle. Thus, to identify the causative factors of CKDu, designing consistent and comparative multisite studies in high-risk populations may help elucidate the importance of region–specific versus global risk factors. Finally, to better characterize the global epidemiology of CKD more broadly, investigators should strive to identify the interactions between global, regional, and local factors.
Disclosures
J.W.S is supported by the American Kidney Fund Clinical Scientist in Nephrology Fellowship. Other authors have no relevant disclosures. Dr. Patel receives support from the National Institute of Diabetes, Digestive and Kidney Diseases of the National Institutes of Health under award numbers R01DK93938, R34DK102166, and P30DK096493.
Supplementary Material
Footnotes
Published online ahead of print. Publication date available at www.cjasn.org.
This article contains supplemental material online at http://cjasn.asnjournals.org/lookup/suppl/doi:10.2215/CJN.07500715/-/DCSupplemental.
References
- 1.Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW: Chronic kidney disease: Global dimension and perspectives. Lancet 382: 260–272, 2013 [DOI] [PubMed] [Google Scholar]
- 2.Couser WG, Remuzzi G, Mendis S, Tonelli M: The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 80: 1258–1270, 2011 [DOI] [PubMed] [Google Scholar]
- 3.Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S, Patel U: The epidemiology of chronic kidney disease in sub-Saharan Africa: A systematic review and meta-analysis. Lancet Glob Health 2: e174–e181, 2014 [DOI] [PubMed] [Google Scholar]
- 4.Orantes CM, Herrera R, Almaguer M, Brizuela EG, Hernández CE, Bayarre H, Amaya JC, Calero DJ, Orellana P, Colindres RM, Velázquez ME, Núñez SG, Contreras VM, Castro BE: Chronic kidney disease and associated risk factors in the Bajo Lempa region of El Salvador: Nefrolempa study, 2009. MEDICC Rev 13: 14–22, 2011 [DOI] [PubMed] [Google Scholar]
- 5.Martin-Cleary C, Ortiz A: CKD hotspots around the world: Where, why and what the lessons are. A CKJ review series. Clin Kidney J 7: 519–523, 2014 [DOI] [PMC free article] [PubMed]
- 6.Correa-Rotter R, Wesseling C, Johnson RJ: CKD of unknown origin in Central America: The case for a Mesoamerican nephropathy. Am J Kidney Dis 63: 506–520, 2014 [DOI] [PMC free article] [PubMed]
- 7.Trabanino RG, Aguilar R, Silva CR, Mercado MO, Merino RL: End-stage renal disease among patients in a referral hospital in El Salvador. Rev Panam Salud Publica 12: 202–206, 2002 [DOI] [PubMed]
- 8.Rodríguez MI: Sounding the alarm on chronic kidney disease in farming communities: María Isabel Rodríguez MD. Minister of health, El Salvador. Interview by Conner Gorry. MEDICC Rev 15: 8–10, 2013 [DOI] [PubMed] [Google Scholar]
- 9.Hall PW, Batuman V: Balkan endemic nephropathy—introduction. Kidney Int 40[Suppl 34]: S1–S3, 1994 [Google Scholar]
- 10.CKDu : CKDu: A perfect storm. MEDICC Rev 16: 3, 2014 [DOI] [PubMed] [Google Scholar]
- 11.Wesseling C, von Wendel de Joode B, Crowe J, Rittner R, Sanati NA, Hogstedt C, Jakobson K: Mesoamerican nephropathy: Geographical distribution and time trends of chronic kidney disease mortality between 1970 and 2012 in Costa Rica. Occup Environ Med 72: 714–721, 2015 [DOI] [PubMed]
- 12.Chandrajith R, Nanayakkara S, Itai K, Aturaliya TN, Dissanayake CB, Abeysekera T, Harada K, Watanabe T, Koizumi A: Chronic kidney diseases of uncertain etiology (CKDue) in Sri Lanka: Geographic distribution and environmental implications. Environ Geochem Health 33: 267–278, 2011 [DOI] [PubMed] [Google Scholar]
- 13.Pan American Health Organization and World Health Organization: Chronic kidney disease in agricultural communities in Central America. Concept paper CE152/25. Presented at 152nd Session of the Executive Committee, Pan American Health Organization and World Health Organization, Washington, DC, June 17–21, 2013
- 14.Elledge MF, Redmon JH, Levine KE, Wickremasinghe RJ, Wanigasariya KP, Peiris-John RJ: Chronic Kidney Disease of Unknown Etiology in Sri Lanka: Quest for Understanding and Global Implications. RTI Research Brief, RTI Press, May 2014. Available at: http://dx.doi.org/10.3768/rtipress.2014.rb.0007.1405. Accessed October 20, 2014 10.3768/rtipress.2014.rb.0007.1405 [DOI] [PubMed]
- 15.Ranasinghe P, Perera YS, Makarim MF, Wijesinghe A, Wanigasuriya K: The costs in provision of haemodialysis in a developing country: A multi-centered study. BMC Nephrol 12: 42, 2011 [DOI] [PMC free article] [PubMed]
- 16.World Health Organization (WHO): Chronic Kidney Disease of Unknown Aetiology (CKDu); A New Threat to Health, WHO Country Office for Sri Lanka, Colombo, Sri Lanka, 2008 [Google Scholar]
- 17.Jayatilake N, Mendis S, Maheepala P, Mehta FR, CKDu National Research Project Team : Chronic kidney disease of uncertain aetiology: Prevalence and causative factors in a developing country. BMC Nephrol 14: 180, 2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Redmon JH, Elledge MF, Womack DS, Wickremashinghe R, Wanigasuriya KP, Peiris-John RJ, Lunyera J, Smith K, Raymer JH, Levine KE: Additional perspectives on chronic kidney disease of unknown aetiology (CKDu) in Sri Lanka--lessons learned from the WHO CKDu population prevalence study. BMC Nephrol 15: 125, 2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Cuadra S, Jakobsson K, Hogstedt C, Wesseling C: Chronic Kidney Disease in Central America. Chronic Kidney Disease: Assessment of Current Knowledge and Feasibility for Regional Research Collaboration in Central America, Vol. 2, Heredia, Costa Rica, SALTRA, 2006 [Google Scholar]
- 20.Torres C, Aragón A, González M, López I, Jakobsson K, Elinder CG, Lundberg I, Wesseling C: Decreased kidney function of unknown cause in Nicaragua: A community-based survey. Am J Kidney Dis 55: 485–496, 2010 [DOI] [PubMed] [Google Scholar]
- 21.Wanigasuriya KP, Peiris-John RJ, Wickremasinghe R: Chronic kidney disease of unknown aetiology in Sri Lanka: Is cadmium a likely cause? BMC Nephrol 12: 32, 2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Laux TS, Bert PJ, Barreto Ruiz GM, González M, Unruh M, Aragon A, Torres Lacourt C: Nicaragua revisited: Evidence of lower prevalence of chronic kidney disease in a high-altitude, coffee-growing village. J Nephrol 25: 533–540, 2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Wanigasuriya KP, Peiris H, Ileperuma N, Peiris-John RJ, Wickremasinghe R: Could ochratoxin A in food commodities be the cause of chronic kidney disease in Sri Lanka? Trans R Soc Trop Med Hyg 102: 726–728, 2008 [DOI] [PubMed] [Google Scholar]
- 24.Wanigasuriya KP, Peiris-John RJ, Wickremasinghe R, Hittarage A: Chronic renal failure in North Central Province of Sri Lanka: An environmentally induced disease. Trans R Soc Trop Med Hyg 101: 1013–1017, 2007 [DOI] [PubMed] [Google Scholar]
- 25.Higginns JPT, Green S, editors: Chapter 6. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration. Available at: http://handbook.cochrane.org/chapter_6/box_6_4_a_cochrane_hsss_2008_sensmax_pubmed.htm. Accessed September 1, 2015
- 26.Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P: The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/nosgen.pdf. Accessed February 10, 2015
- 27.Higgins JPT, Green S, editors: Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0, London, The Cochrane Collaboration, 2011< [Google Scholar]
- 28.Beach HR, Pattanayak KS, Yang JC, Murray BC, Abt RC: Econometric studies of non-industrial private forest management: A review and synthesis. For Policy Econ 7: 261–281, 2005 [Google Scholar]
- 29.Athuraliya NTC, Abeysekera TDJ, Amerasinghe PH, Kumarasiri R, Bandara P, Karunaratne U, Milton AH, Jones AL: Uncertain etiologies of proteinuric-chronic kidney disease in rural Sri Lanka. Kidney Int 80: 1212–1221, 2011 [DOI] [PubMed] [Google Scholar]
- 30.Raines N, González M, Wyatt C, Kurzrok M, Pool C, Lemma T, Weiss I, Marín C, Prado V, Marcas E, Mayorga K, Morales JF, Aragón A, Sheffield P: Risk factors for reduced glomerular filtration rate in a Nicaraguan community affected by Mesoamerican nephropathy. MEDICC Rev 16: 16–22, 2014 [DOI] [PubMed] [Google Scholar]
- 31.O’Donnell JK, Tobey M, Weiner DE, Stevens LA, Johnson S, Stringham P, Cohen B, Brooks DR: Prevalence of and risk factors for chronic kidney disease in rural Nicaragua. Nephrol Dial Transplant 26: 2798–2805, 2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Peraza S, Wesseling C, Aragon A, Leiva R, García-Trabanino RA, Torres C, Jakobsson K, Elinder CG, Hogstedt C: Decreased kidney function among agricultural workers in El Salvador. Am J Kidney Dis 59: 531–540, 2012 [DOI] [PubMed] [Google Scholar]
- 33.Ivey KL, Lewis JR, Lim WH, Lim EM, Hodgson JM, Prince RL: Associations of proanthocyanidin intake with renal function and clinical outcomes in elderly women. PLoS One 8: e71166, 2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Otto WR, Steinemann AC, Wallace LA: Exposure Analysis, Boca Raton, FL, CRC Press, 2007
- 35.Hove M, Ngwerume ET, Muchemwa C: The urban crisis in sub-Saharan Africa. Stability 2: 1–14, 2013 [Google Scholar]
- 36.Agyei-Mensah S, de-Graft Aikins A: Epidemiological transition and the double burden of disease in Accra, Ghana. J Urban Health 87: 879–897, 2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Stanifer JW, Maro V, Egger J, Karia F, Thielman N, Turner EL, Shimbi D, Kilaweh H, Matemu O, Patel UD: The epidemiology of chronic kidney disease in Northern Tanzania: A population-based survey. PLoS One 10: e0124506, 2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Siddarth M, Datta SK, Ahmed RS, Banerjee BD, Kalra OP, Tripathi AK: Association of CYP1A1 gene polymorphism with chronic kidney disease: A case control study. Environ Toxicol Pharmacol 36: 164–170, 2013 [DOI] [PubMed] [Google Scholar]
- 39.Nanayakkara S, Senevirathna STMLD, Abeysekera T, Chandrajith R, Ratnatunga N, Gunarathne ED, Yan J, Hitomi T, Muso E, Komiya T, Harada KH, Liu W, Kobayashi H, Okuda H, Sawatari H, Matsuda F, Yamada R, Watanabe T, Miyataka H, Himeno S, Koizumi A: An integrative study of the genetic, social and environmental determinants of chronic kidney disease characterized by tubulointerstitial damages in the North Central Region of Sri Lanka. J Occup Health 56: 28–38, 2014 [DOI] [PubMed] [Google Scholar]
- 40.Toncheva D, Dimitrov T: Genetic predisposition to Balkan endemic nephropathy. Nephron 72: 564–569, 1996 [DOI] [PubMed] [Google Scholar]
- 41.Batuman V: Fifty years of Balkan endemic nephropathy: Daunting questions, elusive answers. Kidney Int 69: 644–646, 2006 [DOI] [PubMed] [Google Scholar]
- 42.Larsen K, Najle R, Lifschitz A, Virkel G: Effects of sub-lethal exposure of rats to the herbicide glyphosate in drinking water: Glutathione transferase enzyme activities, levels of reduced glutathione and lipid peroxidation in liver, kidneys and small intestine. Environ Toxicol Pharmacol 34: 811–818, 2012 [DOI] [PubMed] [Google Scholar]
- 43.Ekong EB, Jaar BG, Weaver VM: Lead-related nephrotoxicity: A review of the epidemiologic evidence. Kidney Int 70: 2074–2084, 2006 [DOI] [PubMed] [Google Scholar]
- 44.Teeyakasem W, Nishijo M, Honda R, Satarug S, Swaddiwudhipong W, Ruangyuttikarn W: Monitoring of cadmium toxicity in a Thai population with high-level environmental exposure. Toxicol Lett 169: 185–195, 2007 [DOI] [PubMed] [Google Scholar]
- 45.Rango T, Jeuland M, Manthrithilake H, McCornick P: Nephrotoxic contaminants in drinking water and urine, and chronic kidney disease in rural Sri Lanka. Sci Total Environ 518-519: 574–585, 2015 [DOI] [PubMed] [Google Scholar]
- 46.Jayasumana C, Gunatilake S, Senanayake P: Glyphosate, hard water and nephrotoxic metals: Are they the culprits behind the epidemic of chronic kidney disease of unknown etiology in Sri Lanka? Int J Environ Res Public Health 11: 2125–2147, 2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Siriwardhana EA, Perera PA, Sivakanesan R, Abeysekara T, Nugegoda DB, Weerakoon KG: Is the staple diet eaten in Medawachchiya, Sri Lanka, a predisposing factor in the development of chronic kidney disease of unknown etiology? - A comparison based on urinary β2-microglobulin measurements. BMC Nephrol 15: 103, 2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Bandara JM, Senevirathna DM, Dasanayake DM, Herath V, Bandara JM, Abeysekara T, Rajapaksha KH: Chronic renal failure among farm families in cascade irrigation systems in Sri Lanka associated with elevated dietary cadmium levels in rice and freshwater fish (Tilapia). Environ Geochem Health 30: 465–478, 2008 [DOI] [PubMed] [Google Scholar]
- 49.Nanayakkara S, Senevirathna ST, Karunaratne U, Chandrajith R, Harada KH, Hitomi T, Watanabe T, Abeysekera T, Aturaliya TN, Koizumi A: Evidence of tubular damage in the very early stage of chronic kidney disease of uncertain etiology in the North Central Province of Sri Lanka: A cross-sectional study. Environ Health Prev Med 17: 109–117, 2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.VanDervort DR, López DL, Orantes CM, Rodríguez DS: Spatial distribution of unspecified chronic kidney disease in El Salvador by crop area cultivated and ambient temperature. MEDICC Rev 16: 31–38, 2014 [DOI] [PubMed] [Google Scholar]
- 51.Sanoff SL, Callejas L, Alonso CD, Hu Y, Colindres RE, Chin H, Morgan DR, Hogan SL: Positive association of renal insufficiency with agriculture employment and unregulated alcohol consumption in Nicaragua. Ren Fail 32: 766–777, 2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Maruzeni S, Nishijo M, Nakamura K, Morikawa Y, Sakurai M, Nakashima M, Kido T, Okamoto R, Nogawa K, Suwazono Y, Nakagawa H: Mortality and causes of deaths of inhabitants with renal dysfunction induced by cadmium exposure of the polluted Jinzu River basin, Toyama, Japan; a 26-year follow-up. Environ Health 13: 18, 2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Robles-Osorio ML, Pérez-Maldonado IN, Martín del Campo D, Montero-Perea D, Avilés-Romo I, Sabath-Silva E, Sabath E: Urinary arsenic levels and risk of renal injury in a cross-sectional study in open population. Rev Invest Clin 64: 609–614, 2012 [PubMed] [Google Scholar]
- 54.Sommar JN, Svensson MK, Björ BM, Elmståhl SI, Hallmans G, Lundh T, Schön SM, Skerfving S, Bergdahl IA: End-stage renal disease and low level exposure to lead, cadmium and mercury; a population-based, prospective nested case-referent study in Sweden. Environ Health 12: 9, 2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Abid S, Hassen W, Achour A, Skhiri H, Maaroufi K, Ellouz F, Creppy E, Bacha H: Ochratoxin A and human chronic nephropathy in Tunisia: Is the situation endemic? Hum Exp Toxicol 22: 77–84, 2003 [DOI] [PubMed] [Google Scholar]
- 56.Sontrop JM, Dixon SN, Garg AX, Buendia-Jimenez I, Dohein O, Huang SH, Clark WF: Association between water intake, chronic kidney disease, and cardiovascular disease: A cross-sectional analysis of NHANES data. Am J Nephrol 37: 434–442, 2013 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.